The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor α genotype in early postmenopausal women

Journal of Bone and Mineral Research

Volumn 15, Issue 12, 2000, Pages 2479-2486

  Salmén, Timo ^a   Heikkinen, Anna Mari ^b   Mahonen, Anitta ^a   Kröger, Heikki ^b   Komulainen, Marja ^b   Saarikoski, Seppo ^b   Honkanen, Risto ^a   Mäenpää, Pekka H ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Estrogen receptor; Fracture; Hormone replacement therapy; Menopause; Osteoporosis

Indexed keywords

CALCIUM LACTATE; COLECALCIFEROL; CYPROTERONE ACETATE; ESTRADIOL VALERATE; ESTROGEN RECEPTOR ALPHA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; FRACTURE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL;

ANDROGEN ANTAGONISTS; CYPROTERONE ACETATE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; GENOTYPE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RISK;

EID: 0033725191     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.12.2479     Document Type: Article

References (41)

1. Genetic determinants of bone mass in adults: A twin study
2. Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: A twin study
3. Segregation analysis and variance components analysis of bone mineral density in healthy families
4. Prediction of bone density from vitamin D receptor alleles
5. Vitamin D receptor genotypes and bone mineral density
6. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis
7. Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women
8. Bone mineral density and its change in white women: Estrogen and vitamin D receptor genotypes and their interaction
9. Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes
10. Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women
11. Early postmenopausal bone loss is associated with Pvu II estrogen receptor gene polymorphism in Finnish women: Effect of hormone replacement therapy
12. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene
13. Relation of alleles of the collagen type I alpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women
14. Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover
15. Association of bone mineral density with apolipoprotein E phenotype
16. Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women
17. Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: Studies in a UK population
18. FokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women
19. Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype
20. Long-term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment
21. Involutional osteoporosis
22. 3 in early postmenopausal women: A population-based 5-year randomized trial
23. Treatment of postmenopausal osteoporosis with transdermal estrogen
24. HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women: A 5 year randomized trial
25. Prediction of rapid bone loss in postmenopausal women
26. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study
27. Osteoporosis risk factors, gynecological history and fractures in perimenopausal women - The results of the baseline postal inquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study
28. Vitamin D and HRT: No benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized, placebo-controlled study
29. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3 - A prospective, controlled, randomized study
30. PvuII RFLP inside the human estrogen receptor gene
31. Insights from the study of animals lacking functional estrogen receptor
32. Estrogen resistance caused by a mutation in the estrogen receptor gene in a man
33. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women
34. Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women
35. Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss; do they exist?
36. Identification of early postmenopausal women with no bone response to HRT: Results of a 5-year clinical trial
37. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique
38. A bone morphogenetic protein subfamily: Chromosomal localization of human genes for BMP5, BMP6, and BMP7
39. Ultrasonographic heel measurements to predict hip fracture in elderly women: The EPIDOS prospective study
40. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
41. Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D